ArticleClinical drug investigation2003
Postmarketing surveillance study of the efficacy and tolerability of pioglitazone in insulin-resistant patients with type 2 diabetes mellitus in general practice.
Christof Schöfl et al.PubMed ↗Publisher ↗
No numbers read from the abstract.